Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years
AMOS
2 other identifiers
observational
180
1 country
1
Brief Summary
The mechanism of bone loss in anorexia nervosa is complex. Marrow adipose tissue seems to play a role in the regulation of bone metabolism. Adipocytes secrete cytokines and adipokines that either stimulate or inhibit adjacent osteoblasts. This study consist to explore the relationship in anorexia nervosa patients with change in bone mineral density and adipokines like leptin, adiponectin and Préf-1 Bone mineral densities will be measure in 180 anorexia nervosa patients at inclusion and every two years during 6 years.It is assessed blood and urinary calcium and phosphate levels, bone remodelling markers and adipokines (leptin, adiponectin and Préf-1)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 1, 2016
CompletedFirst Posted
Study publicly available on registry
September 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedDecember 8, 2025
November 1, 2025
9.4 years
September 1, 2016
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone mineral density by Dual Energy X-ray Absorptiometry (DEXA)
measured the evolution of the bone mineral density in 180 anorexia nervosa patients and the relationship with this change and adipokine
4 years
Secondary Outcomes (3)
Incidence of osteoporotic fractures
at 2,4 and 6 years
Adiponectin plasma concentration by ELISA
at 2,4 and 6 years
Interleukin-7 plasma concentration by ELISA
at 2,4 and 6 years
Study Arms (1)
Anorexia patient
Dual Energy X-ray Absorptiometry (DEXA)
Interventions
The Dual Energy X-ray Absorptiometry (DEXA) is a third generation multi-captor DEXA device that allow short duration measurements. It measures Bone Mineral Density (BMD) at the spine and the femoral neck
Eligibility Criteria
Anorexia patient recruted in psychiatric unit ( hospitalisation and consultation visit)
You may qualify if:
- anorexia patient defined by DSM IV diagnostic criteria
You may not qualify if:
- patient with other psychiatric disease
- patient with other a metabolic bone disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Roger Salengro, CHRU de Lille
Lille, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Isabelle LEGROUX, MD
University Hospital, Lille
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2016
First Posted
September 7, 2016
Study Start
July 1, 2013
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
December 8, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share